Ownership history in Qube Research & Technologies Ltd · 11 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 21,730 | -8,949 | -29.2% | 0.00% | $98K | — |
| 2025 Q2 | ADDED | 30,679 | +14,414 | +88.6% | 0.00% | $66K | — |
| 2024 Q2 | REDUCED | 16,265 | -25,354 | -60.9% | 0.00% | $112K | — |
| 2024 Q1 | ADDED | 41,619 | +40,902 | +5704.6% | 0.00% | $588K | — |
| 2023 Q4 | REDUCED | 717 | -24,250 | -97.1% | 0.00% | $540 | — |
| 2023 Q3 | REDUCED | 24,967 | -42,597 | -63.0% | 0.00% | $37K | — |
| 2022 Q3 | REDUCED | 67,564 | -16,322 | -19.5% | 0.00% | $64K | — |
| 2022 Q2 | ADDED | 83,886 | +60,224 | +254.5% | 0.00% | $101K | — |
| 2021 Q3 | ADDED | 23,662 | +12,221 | +106.8% | 0.00% | $51K | — |
| 2020 Q4 | REDUCED | 11,441 | -19,710 | -63.3% | 0.00% | $124K | — |
As of 2025 Q3 — sorted by position size